Mechanisms Behind the Pharmacological Application of Biochanin-A: A review

This review was aimed at summarizing the cellular and molecular mechanisms behind the various pharmacological actions of biochanin-A. Many studies have been reported claiming its application in cancers, metabolic disorders, airway hyperresponsiveness, cardiac disorders, neurological disorders, etc. With regard to hormone-dependent cancers like breast, prostate, and other malignancies like pancreatic, colon, lung, osteosarcoma, glioma that has limited treatment options, biochanin-A revealed agreeable results in arresting cancer development. Biochanin-A has also shown therapeutic benefits when administered for neurological disorders, diabetes, hyperlipidaemia, and other chronic diseases/disorders. Isoflavones are considered phenomenal due to their high efficiency in modifying the physiological functions of the human body. Biochanin-A is one among the prominent isoflavones found in soy (glycine max), red clover (Trifolium pratense), and alfalfa sprouts, etc., with proven potency in modulating vital cellular mechanisms in various diseases. It has been popular for ages among menopausal women in controlling symptoms. In view of the multi-targeted functions of biochanin-A, it is essential to summarize it's mechanism of action in various disorders. The safety and efficacy of biochanin-A need to be established in clinical trials involving human subjects. Biochanin-A might be able to modify various systems of the human body like the cardiovascular system, CNS, respiratory system, etc. It has shown a remarkable effect on hormonal cancers and other cancers. Many types of research on biochanin-A, particularly in breast, lung, colon, prostate, and pancreatic cancers, have shown a positive impact. Through modulating oxidative stress, SIRT-1 expression, PPAR gamma receptors, and other multiple mechanisms biochanin-A produces anti-diabetic action. The diverse molecular mechanistic pathways involved in the pharmacological ability of biochanin-A indicate that it is a very promising molecule and can play a major impact in modifying several physiological functions.

[1]  G. Ashraf,et al.  Biochanin A Improves Memory Decline and Brain Pathology in Cuprizone-Induced Mouse Model of Multiple Sclerosis , 2022, Behavioral sciences.

[2]  Manisha J. Oza,et al.  Biochanin A Attenuates Cardiomyopathy in Type 2 Diabetic Rats by Increasing SIRT1 Expression and Reducing Oxidative Stress , 2022, Chemistry & biodiversity.

[3]  S. Zada,et al.  The natural isoflavone Biochanin‐A synergizes 5‐fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid‐phase carcinoma model , 2022, Phytotherapy research : PTR.

[4]  Degui Wang,et al.  Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy , 2022, Molecular neurobiology.

[5]  G. McCabe,et al.  Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models. , 2021, Food & function.

[6]  Zhaohui Xue,et al.  Investigation on the mechanisms of biochanin A alleviate PM10-induced acute pulmonary cell injury. , 2021, Ecotoxicology and environmental safety.

[7]  M. Salehi,et al.  Biochanin‐A has antidiabetic, antihyperlipidemic, antioxidant, and protective effects on diabetic nephropathy via suppression of TGF‐β1 and PAR‐2 genes expression in kidney tissues of STZ‐induced diabetic rats , 2021, Biotechnology and applied biochemistry.

[8]  D. Harmon,et al.  Effect of biochanin A on the rumen microbial community of Holstein steers consuming a high fiber diet and subjected to a subacute acidosis challenge , 2021, PloS one.

[9]  K. Ozawa,et al.  The possible role of biochanin A in ameliorating endoplasmic reticulum stress-induced leptin resistance , 2021, Neuroreport.

[10]  M. Teixeira,et al.  Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism , 2021, Frontiers in Pharmacology.

[11]  Wei Zhao,et al.  Biochanin A Attenuates Ovariectomy-Induced Cognition Deficit via Antioxidant Effects in Female Rats , 2021, Frontiers in Pharmacology.

[12]  Xin Gao,et al.  Biochanin A alleviates oxidative damage caused by the urban particulate matter. , 2021, Food & function.

[13]  V. Uddandrao,et al.  Biochanin A attenuates obesity cardiomyopathy in rats by inhibiting oxidative stress and inflammation through the Nrf-2 pathway , 2021, Archives of physiology and biochemistry.

[14]  M. Mehrabadi,et al.  Effect of Biochanin A on Serum Nesfatin-1 Level in STZ Induced Type 1 Diabetic Rat , 2016, Traditional and Integrative Medicine.

[15]  S. Singh,et al.  A novel nanosized phospholipid complex of Biochanin A for improving oral bioavailability: Preparation and in-vitro/in-vivo characterizations , 2020 .

[16]  Xiao-Hua Yu,et al.  Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response , 2020, Oxidative medicine and cellular longevity.

[17]  Tae-Jin Lee,et al.  Biochanin A induces a brown‐fat phenotype via improvement of mitochondrial biogenesis and activation of AMPK signaling in murine C3H10T1/2 mesenchymal stem cells , 2020, Phytotherapy research : PTR.

[18]  Zhongliang Wang,et al.  Amelioration of PM2.5-induced lung toxicity in rats by nutritional supplementation with biochanin A. , 2020, Ecotoxicology and environmental safety.

[19]  K. Panati,et al.  Biochanin A Ameliorates Ovalbumin-induced Airway Inflammation through Peroxisome Proliferator-activated Receptor-Gamma in a Mouse Model. , 2020, Endocrine, metabolic & immune disorders drug targets.

[20]  T. Toda,et al.  Soybean isoflavone can protect against osteoarthritis in ovariectomized rats , 2020, Journal of Food Science and Technology.

[21]  V. Uddandrao,et al.  Antiobesity effect of Biochanin-A: Effect on trace element metabolism in high fat diet-induced obesity in rats. , 2020, Cardiovascular & hematological agents in medicinal chemistry.

[22]  V. Uddandrao,et al.  Therapeutic potential of biochanin-A against isoproterenol -induced myocardial infarction in rats. , 2020, Cardiovascular & hematological agents in medicinal chemistry.

[23]  H. Sadri,et al.  Effects of Biochanin A on Resistin, Adiponectin and some stress oxidative markers in normal and STZ- Induced Diabetic Rats , 2020 .

[24]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[25]  Min Liu,et al.  Biochanin A attenuates myocardial ischemia/reperfusion injury through the TLR4/NF-κB/NLRP3 signaling pathway 1 , 2019, Acta cirurgica brasileira.

[26]  Jian Chen,et al.  Biochanin A Provides Neuroprotection Against Cerebral Ischemia/Reperfusion Injury by Nrf2-Mediated Inhibition of Oxidative Stress and Inflammation Signaling Pathway in Rats , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[27]  Kuo-Hu Chen,et al.  Isoflavone Supplements for Menopausal Women: A Systematic Review , 2019, Nutrients.

[28]  Siyi Pan,et al.  Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells. , 2019, BioFactors.

[29]  M. Goodarzi,et al.  The Effect of Biochanin A as PPAR γ agonist on LDL Particles Diameter and Type 2 Diabetic Dyslipidemia , 2019, International Journal of Medical Laboratory.

[30]  Y. Liu,et al.  Aggravated behavioral and neurochemical deficits and redox imbalance in mice with enhanced neonatal iron intake: improvement by biochanin A and role of microglial p38 activation , 2019, Nutritional neuroscience.

[31]  Xuan Shi,et al.  Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A , 2019, Evidence-based complementary and alternative medicine : eCAM.

[32]  S. Bierma-Zeinstra,et al.  Osteoarthritis , 2006, The Lancet.

[33]  Aditi Jain,et al.  Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme , 2019, AntiCancer Research.

[34]  Manisha J. Oza,et al.  Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Yan Li,et al.  Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells , 2018, BioMed research international.

[36]  Mingyuan Liu,et al.  Biochanin a Enhances the Defense Against Salmonella enterica Infection Through AMPK/ULK1/mTOR-Mediated Autophagy and Extracellular Traps and Reversing SPI-1-Dependent Macrophage (MΦ) M2 Polarization , 2018, Front. Cell. Infect. Microbiol..

[37]  V. Lather,et al.  Biochanin A: A phytoestrogen with therapeutic potential , 2018, Trends in Food Science & Technology.

[38]  A. Bhushan,et al.  Abstract 4193: Biochanin A in pancreatic cancer , 2018, Tumor Biology.

[39]  A. Rigby,et al.  Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[40]  N. Neamati,et al.  Current Challenges and Opportunities in Treating Glioblastoma , 2018, Pharmacological Reviews.

[41]  Ling Wang,et al.  The effect of biochanin A on cell growth, apoptosis, and migration in osteosarcoma cells. , 2018, Die Pharmazie.

[42]  M. Mehrabadi,et al.  Effect of Biochanin A on Retina Levels of Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha and Interleukin-1Beta in Rats With Streptozotocin-Induced Diabetes. , 2018, Canadian journal of diabetes.

[43]  L. Facci,et al.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron , 2018, Front. Cell. Neurosci..

[44]  Y. Yeh,et al.  Anti-proliferative activity of biochanin A in human osteosarcoma cells via mitochondrial-involved apoptosis. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[45]  Yan Wang,et al.  Biochanin A extirpates the epithelial-mesenchymal transition in a human lung cancer , 2018, Experimental and therapeutic medicine.

[46]  J. Erdman,et al.  Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis , 2018, Nutrients.

[47]  V. Singh,et al.  Kenkyu Journal of Pharmacy Practice & Health Care 4:56-60 (2018) Review Antidiabetic Medicinal Plants Having Insulin Mimetic Property: A Review , 2018 .

[48]  A. Klatsky,et al.  Low Cancer Risk of South Asians: A Brief Report. , 2018, The Permanente journal.

[49]  Hanqing Chen,et al.  Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A , 2017, Front. Neurosci..

[50]  A. Bhushan,et al.  Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme , 2017, BioMed research international.

[51]  Gang Li,et al.  Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice , 2017, PloS one.

[52]  A. Mallick,et al.  The Effect of Soy Isoflavones on the Menopause Rating Scale Scoring in Perimenopausal and Postmenopausal Women: A Pilot Study. , 2017, Journal of clinical and diagnostic research : JCDR.

[53]  M. Goodarzi,et al.  Antioxidant Effects of Biochanin A in Streptozotocin Induced Diabetic Rats , 2017 .

[54]  F. Pakdel,et al.  Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects? , 2017, International journal of molecular sciences.

[55]  S. Gnyawali,et al.  Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  Zhaohui Xue,et al.  Potential Lipid-Lowering Mechanisms of Biochanin A. , 2017, Journal of agricultural and food chemistry.

[57]  R. Halaby,et al.  Dietary Isoflavones and Breast Cancer Risk , 2017, Medicines.

[58]  Pengshou Li,et al.  Study of the Hypoglycemic Activity of Derivatives of Isoflavones from Cicer arietinum L. , 2017, Evidence-based complementary and alternative medicine : eCAM.

[59]  M. Tolba,et al.  Abstract B47: A novel combination of Biochanin-A/ 5-Fluorouracil against colon cancer: Impact on Wnt/beta-catenin signaling , 2017 .

[60]  Sheela Chandra,et al.  Flavonoids: an overview , 2016, Journal of Nutritional Science.

[61]  C. Gridelli,et al.  Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell Lines. , 2016, Anticancer research.

[62]  S. Challa,et al.  Biochanin-A attenuates neuropathic pain in diabetic rats , 2016, Journal of Ayurveda and integrative medicine.

[63]  Jinhyuk Lee,et al.  The Identification of Biochanin A as a Potent and Selective β-Site App-Cleaving Enzyme 1 (Bace1) Inhibitor , 2016, Nutrients.

[64]  D. Kwon,et al.  Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. , 2016, Molecular nutrition & food research.

[65]  Jun Wang,et al.  Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation , 2016, Neurotoxicity Research.

[66]  O. Franco,et al.  Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. , 2016, JAMA.

[67]  Amei Amei,et al.  Cancer incidence among Asian American populations in the United States, 2009–2011 , 2016, International journal of cancer.

[68]  J. Tan,et al.  Neuroprotective Effects of Biochanin A against β-Amyloid-Induced Neurotoxicity in PC12 Cells via a Mitochondrial-Dependent Apoptosis Pathway , 2016, Molecules.

[69]  M. J. Miller Nutrient-Microbiome interactions: Historical considerations and future trends , 2016 .

[70]  Baojun Xu,et al.  Antidiabetic properties of dietary flavonoids: a cellular mechanism review , 2015, Nutrition & Metabolism.

[71]  E. Norkevičienė,et al.  The concentration of isoflavones in red clover (Trifolium pratense L.) at flowering stage. , 2015 .

[72]  Jun Wang,et al.  Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease , 2015, Pharmacology Biochemistry and Behavior.

[73]  P. Gál,et al.  Soy and Breast Cancer: Focus on Angiogenesis , 2015, International journal of molecular sciences.

[74]  Aditi Jain,et al.  Biochanin A inhibits endothelial cell functions and proangiogenic pathways: implications in glioma therapy. , 2015, Anti-cancer drugs.

[75]  L. Kokoska,et al.  The relationship between structure and in vitro antibacterial activity of selected isoflavones and their metabolites with special focus on antistaphylococcal effect of demethyltexasin , 2015, Letters in applied microbiology.

[76]  Huan Huang,et al.  Biochanin A attenuates LPS-induced pro-inflammatory responses and inhibits the activation of the MAPK pathway in BV2 microglial cells. , 2015, International journal of molecular medicine.

[77]  Wenbo Wang,et al.  Biochanin A protects against focal cerebral ischemia/reperfusion in rats via inhibition of p38-mediated inflammatory responses , 2015, Journal of the Neurological Sciences.

[78]  N. Sandler,et al.  Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation , 2014, PloS one.

[79]  H. Zhong,et al.  Protective effects of biochanin A on articular cartilage: in vitro and in vivo studies , 2014, BMC Complementary and Alternative Medicine.

[80]  Dawn V Tomy,et al.  Diabetes mellitus and medicinal plants-a review , 2014 .

[81]  Z. Salemi,et al.  Effect of Biochanin A on Serum Visfatin Level of Streptozocin-Induced Diabetic Rats , 2014, Iranian Red Crescent medical journal.

[82]  A. Doerfler,et al.  The impact of dietary isoflavonoids on malignant brain tumors , 2014, Cancer medicine.

[83]  H. Joshi,et al.  Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease , 2014, Human & experimental toxicology.

[84]  V. Bhardwaj,et al.  Biochanin A reduces pancreatic cancer survival and progression , 2014, Anti-cancer drugs.

[85]  Yang Zhang,et al.  Biochanin A Inhibits Lipopolysaccharide-Induced Inflammatory Cytokines and Mediators Production in BV2 Microglia , 2014, Neurochemical Research.

[86]  N. Anitha Influence of ayurvedic antidiabetic agent on the pharmacodynamics of glimepiride , 2013 .

[87]  Jin-Qiang Chen,et al.  Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms , 2013 .

[88]  D. Kang,et al.  Intake of Soy Products and Other Foods and Gastric Cancer Risk: A Prospective Study , 2013, Journal of epidemiology.

[89]  Kuan-Ming Chen,et al.  Biochanin A Promotes Osteogenic but Inhibits Adipogenic Differentiation: Evidence with Primary Adipose-Derived Stem Cells , 2013, Evidence-based complementary and alternative medicine : eCAM.

[90]  Yu Qin,et al.  Isoflavones for hypercholesterolaemia in adults. , 2013, The Cochrane database of systematic reviews.

[91]  A. Abdel-Naim,et al.  Biochanin A Protects against Acute Carbon Tetrachloride-Induced Hepatotoxicity in Rats , 2013, Bioscience, biotechnology, and biochemistry.

[92]  T. He,et al.  Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells , 2013, International journal of oncology.

[93]  K. Asokkumar,et al.  Discovery of potential cholesterol esterase inhibitors using in silico docking studies , 2013 .

[94]  W. Krol,et al.  The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis. , 2013, Urologic oncology.

[95]  I. Ferrer,et al.  GC–MS–MS for the Analysis of Phytoestrogens in the Environment , 2013 .

[96]  K. Mishra,et al.  Biochanin A enhances the radiotoxicity in colon tumor cells in vitro. , 2013, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[97]  D. Israf,et al.  Neuroprotective Effects of Biochanin A Against Glutamate-Induced Cytotoxicity in PC12 Cells Via Apoptosis Inhibition , 2012, Neurochemical Research.

[98]  Limei Chen,et al.  Red clover extract exerts antidiabetic and hypolipidemic effects in db/db mice , 2012, Experimental and therapeutic medicine.

[99]  Limei Chen,et al.  Red Clover Extract Ameliorates Dyslipidemia in Streptozotocin‐induced Diabetic C57BL/6 Mice by Activating Hepatic PPARα , 2012, Phytotherapy research : PTR.

[100]  S. Hemalatha,et al.  An overview on antidiabetic medicinal plants having insulin mimetic property. , 2012, Asian Pacific journal of tropical biomedicine.

[101]  J. Peñalvo,et al.  Soy isoflavones and cardiovascular disease epidemiological, clinical and -omics perspectives. , 2012, Current pharmaceutical biotechnology.

[102]  M. Ezhumalai,et al.  Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. , 2012, European journal of pharmacology.

[103]  Liu Meng-jiang Antiatheroscloresis effects of biochanin A on hyperlipidemia rats , 2012 .

[104]  S. Rani,et al.  A REVIEW ON DIABETES MILLETUS AND THE HERBAL PLANTS USED FOR ITS TREATMENT , 2012 .

[105]  M. Wong,et al.  Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. , 2011, The American journal of clinical nutrition.

[106]  S. Chun,et al.  Apoptotic Effects of Genistein, Biochanin-A and Apigenin on LNCaP and PC-3 Cells by p21 through Transcriptional Inhibition of Polo-like Kinase-1 , 2011, Journal of Korean medical science.

[107]  G. Hillman,et al.  Soy isoflavones sensitize cancer cells to radiotherapy. , 2011, Free radical biology & medicine.

[108]  F. Sarkar,et al.  Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[109]  W. Ko,et al.  Biochanin A, a Phytoestrogenic Isoflavone with Selective Inhibition of Phosphodiesterase 4, Suppresses Ovalbumin-Induced Airway Hyperresponsiveness , 2011, Evidence-based complementary and alternative medicine : eCAM.

[110]  S. Manna,et al.  Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NFκB nuclear translocation. , 2011, European journal of pharmacology.

[111]  Qingyuan Zhang,et al.  Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy , 2010, Canadian Medical Association Journal.

[112]  Wei Zheng,et al.  Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). , 2010, Archives of internal medicine.

[113]  J. Malik,et al.  Selective Growth Inhibitory Effect of Biochanin A Against Intestinal Tract Colonizing Bacteria , 2010, Molecules.

[114]  E. Spitznagel,et al.  Soy Consumption and Colorectal Cancer Risk in Humans: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[115]  A. Bhushan,et al.  Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells , 2010, Journal of oncology.

[116]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[117]  L. Hilakivi-Clarke,et al.  Early Intake Appears to Be the Key to the Proposed Protective Effects of Soy Intake Against Breast Cancer , 2009, Nutrition and cancer.

[118]  A. Azmi,et al.  Cellular DNA breakage by soy isoflavone genistein and its methylated structural analogue biochanin A. , 2009, Molecular nutrition & food research.

[119]  Zhiwei Wang,et al.  Cellular signaling perturbation by natural products. , 2009, Cellular signalling.

[120]  J. Malik,et al.  Selective antimicrobial activity of biochanin A , 2009 .

[121]  Jeffrey S. Morris,et al.  Body Mass Index and Risk , Age of Onset , and Survival in Patients With Pancreatic Cancer , 2009 .

[122]  S. Passamonti,et al.  Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. , 2009, Current drug metabolism.

[123]  F. Occhiuto,et al.  The isoflavones mixture from Trifolium pratense L. protects HCN 1‐A neurons from oxidative stress , 2009, Phytotherapy research : PTR.

[124]  K. Alberti,et al.  Diagnosis and Classification of Diabetes Mellitus , 2009, Diabetes Care.

[125]  Y. Yamori,et al.  Isoflavones regulate secretion of leukemia inhibitory factor and transforming growth factor {beta} and expression of glycodelin in human endometrial epithelial cells. , 2008, The Journal of endocrinology.

[126]  A. Jungbauer,et al.  Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[127]  T. Hei,et al.  Phytoestrogens and Breast Cancer Prevention: Possible Mechanisms of Action , 2008, Environmental health perspectives.

[128]  S. Zeisel,et al.  Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis and estrogenic outcomes in healthy, post‐menopausal women ‐ a Phase I clinical trial , 2007, Menopause.

[129]  T. Kulik,et al.  Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. , 2007, Journal of medicinal chemistry.

[130]  K. Hatakeyama,et al.  Soy‐derived isoflavones inhibit the growth of adult T‐cell leukemia cells in vitro and in vivo , 2007, Cancer science.

[131]  M. Saif,et al.  Genetic alterations in pancreatic cancer. , 2007, World journal of gastroenterology.

[132]  Guan-Hong Li,et al.  Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation , 2007, Neuroscience Letters.

[133]  S. Whitehead,et al.  Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[134]  E. Han,et al.  Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells , 2006, Archives of pharmacal research.

[135]  R. Miike,et al.  Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study , 2006, BMC Cancer.

[136]  Shilpa Puli,et al.  Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) Cells by isoflavones , 2006, Journal of Neuro-Oncology.

[137]  Mei Hui Liu,et al.  Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. , 2006, The Journal of nutrition.

[138]  F. Sacks,et al.  Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee , 2006, Circulation.

[139]  R. Michael McClain,et al.  Genetic toxicity studies with genistein. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[140]  P. Maisonneuve,et al.  Risk factors for pancreatic cancer , 2005, Journal of cellular biochemistry.

[141]  D. Bostwick,et al.  Human prostate cancer risk factors , 2004, Cancer.

[142]  G. Thompson Management of dyslipidaemia , 2004, Heart.

[143]  P. Nestel,et al.  A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men , 2004, European Journal of Clinical Nutrition.

[144]  B. Jacobsen,et al.  Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States) , 1998, Cancer Causes & Control.

[145]  S. Beghelli,et al.  Genetic abnormalities in pancreatic cancer , 2003, Molecular Cancer.

[146]  A. Husband,et al.  Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[147]  G. Blackburn,et al.  Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components , 2002, The Prostate.

[148]  H. Baker,et al.  Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts * , 2002, The Prostate.

[149]  Ronald D Snyder,et al.  Evaluation of the clastogenic, DNA intercalative, and topoisomerase II‐interactive properties of bioflavonoids in Chinese hamster V79 cells , 2002, Environmental and molecular mutagenesis.

[150]  A. Husband,et al.  In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor β and E-cadherin expression but decrease transforming growth factor β1 , 2002, Prostate Cancer and Prostatic Diseases.

[151]  K. Setchell,et al.  Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. , 2001, The Journal of nutrition.

[152]  M. Summa,et al.  Soy Protein in the Management of Hyperlipidemia , 2000, The Annals of pharmacotherapy.

[153]  Morris Pollard,et al.  Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. , 2000, In vivo.

[154]  S. Pilch Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. , 1999, Federal register.

[155]  R. Hayes,et al.  Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. , 1998, Journal of the National Cancer Institute.

[156]  J. Le Bail,et al.  Aromatase and 17beta-hydroxysteroid dehydrogenase inhibition by flavonoids. , 1998, Cancer letters.

[157]  J. Kavanagh,et al.  Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. , 1998, British journal of urology.

[158]  J. Phang,et al.  Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. , 1998, Cancer research.

[159]  K. Dohi,et al.  Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Carcinogenesis by Soy Foods or Biochanin A , 1998, Japanese journal of cancer research : Gann.

[160]  N. Mak,et al.  Effects of biochanin A on the growth and differentiation of myeloid leukemia WEHI-3B (JCS) cells. , 1997, Life sciences.

[161]  J. McLachlan,et al.  The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast , 1997, Steroids.

[162]  K. Griffiths,et al.  Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. , 1995, The Journal of endocrinology.

[163]  H. Kizaki,et al.  Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells. , 1995, Journal of biochemistry.

[164]  K. Yanagihara,et al.  Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. , 1993, Cancer research.

[165]  D. Campbell,et al.  Flavonoid inhibition of aromatase enzyme activity in human preadipocytes , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[166]  S. Barnes,et al.  Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation , 1993, The Prostate.

[167]  Y. Lee,et al.  Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. , 1991, Journal of Korean medical science.

[168]  P. Boyle,et al.  A case-control study of diet and cancer of the pancreas. , 1991, American journal of epidemiology.